Co-Authors
This is a "connection" page, showing publications co-authored by MARTA PENAS-PRADO and IAN E MCCUTCHEON.
Connection Strength
0.552
-
Treatment and long-term outcomes in pituitary carcinoma: a cohort study. Eur J Endocrinol. 2019 Oct; 181(4):397-407.
Score: 0.174
-
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 2016 Aug; 19(4):415-21.
Score: 0.140
-
Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study. J Immunother Cancer. 2020 12; 8(2).
Score: 0.047
-
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
Score: 0.045
-
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma. Brain Tumor Pathol. 2015 Apr; 32(2):105-11.
Score: 0.031
-
Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report. Clin Neuropathol. 2014 Nov-Dec; 33(6):407-11.
Score: 0.031
-
Intracranial hemangiopericytoma: patterns of failure and the role of radiation therapy. Neurosurgery. 2013 Oct; 73(4):624-30; discussion 630-1.
Score: 0.029
-
Intracranial hemangiopericytoma and the role of radiation therapy: a population based analysis. Neurosurgery. 2013 Feb; 72(2):203-9.
Score: 0.027
-
Treatment, prognostic factors, and outcomes in spinal cord astrocytomas. Neuro Oncol. 2013 Apr; 15(4):406-12.
Score: 0.027